期刊文献+

ST2与心肌梗死和心力衰竭的关系 被引量:15

Relationship between ST2 and myocardial infarction or heart failure
下载PDF
导出
摘要 白介素1(interleukin-1,IL-1)受体家族包括IL-1R、IL-18R及其辅助蛋白IL-1RAcP、IL-18RAcP等。1989年,ST2作为IL-1受体家族的新成员被发现,之后证实其参与多种病理生理过程,在炎症和变态反应性疾病中发挥重要作用,但因当时未发现其功能性配体,故长期以来ST2一直被认为是一个孤儿受体。直到2005年,IL-33作为ST2的特异性功能配体被发现,于是针对ST2的研究又有了新的进展。
作者 张堃 张新超
出处 《中国心血管杂志》 2012年第4期314-316,共3页 Chinese Journal of Cardiovascular Medicine
关键词 ST2 白介素-33 心肌梗死 心力衰竭 心肌重构 ST2 IL-33 Myocardial infarction Heart failure Cardiac remodeling
  • 相关文献

参考文献21

  • 1Sims JE. IL-1 and IL-18 receptors, and their extended family. Curr Opin Immunol, 2002, 14: 117-122.
  • 2Schmitz J,Owyang A, Oldham E, et al. IL-33, an interleukin-1- like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity, 2005, 23: 479-490.
  • 3Sanada S, Hakuno D, Higgins LJ, et al. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest, 2007, 117: 1538-1549.
  • 4Meisel C, Bonhagen K, L-hning M, et al. Regulation and function of T1/ST2 expression on CD4 + T ceils: induction of type 2 cytokine production by T1/ST2 cross-linking. J Immunol, 2001, 166: 3143-3150.
  • 5Dinarello CA. An IL-1 family member requires caspase-1 processing and signals through the ST2 receptor. Immunity. 2005 ; 23:461-462.
  • 6Ali S, Huber M, Kollewe C, et al. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci U S A, 2007, 104: 18660- 18665.
  • 7Kakkar R,Lee RT. The IL-33/ST2 pathway: therapeutic target and Novel biomarker. Nat Rev Drug Discov, 2008, 7 : 827-840.
  • 8Weinberg EO, Shimpo M, de Keulenaer GW, et al. Expression and Regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation, 2002, 106 : 2961-2966.
  • 9Shimpo M, Morrow DA, Weinberg EO, et al. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation, 2004, 109: 2186-2190.
  • 10Weir RA, Miller AM, Murphy GE, et al. Serum soluble ST2 : a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction. J Am Coil Cardiol, 2010, 55 : 243 -250.

同被引文献107

  • 1Januzzi Jr. J.L.,PeacockW.F.,Maisel A.S.,黄欣.急性呼吸困难患者中白介素家族成员ST2的测定:PRIDE(急诊科呼吸困难患者脑利钠肽前体)研究的结果[J].世界核心医学期刊文摘(心脏病学分册),2007(12):54-55. 被引量:18
  • 2李仁祧,任宏生.心力衰竭的评估标准及常用检测方法[J].山东医药,2005,45(13):68-69. 被引量:23
  • 3范耀东,于乃浩,荀丽颖,丁娜,赵连余.阵发房颤患者复律前后血脑钠肽水平及临床意义[J].天津医科大学学报,2010,16(4):608-612. 被引量:6
  • 4陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2007:712-717.
  • 5Rehman SU, Mueller T, Januzzi JL Jr. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure. J Am Coil Cardiol, 2008, 52: 1458-1465.
  • 6Bayes-Geins A,Pascual-Figal D, Januzzi JL, et al. Soluble ST2 mointoring provides additional risk stratification for outpatients with decompensated heart failure. Rev Esp Cardiol, 2010, 63: 1171-1178.
  • 7Weinberg EO, Shimpo M, De Keulenaer GW, et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in eardiomyoeytes and myocardial infarction. Circulation, 2002, 106 : 2961-2966.
  • 8Chackerian AA,Oldham ER, Murphy EE, et al. IL-1 reeeptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol, 2007, 179 : 2551-2555.
  • 9Rakkar R,Lee RT. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov, 2008, 7: 827-840.
  • 10Miller AM, Liew FY. The 1L-33/ST2 pathway-A new therapeutic target in cardiovascular disease. Pharmacol Ther, 2011, 131 : 179-186.

引证文献15

二级引证文献108

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部